Abstract:
The aim of this study was to optimize, develope and validation
chromatographic and spectroscopic methods for the analysis of atorvastatin
calcium, losartan potassium and their degradation products using an
experimental design.
The methods developed and optimized applying factorial design
approach ;23 which the base 2 denote to levels and exponent 3 denote to the
factors. High performance chromatograph was used and the separation
achieved by column C18 the detection wavelength was 246nm. A linear
response was observed in the range of 6.4 μg/ml-9.6 μg/ml with correlation
coefficient of 0.999 for method No1and 0.9998 for method No2 of analysis
of atorvastatin calcium.
The methods were validated for precision,accuracy, robustness and
recovery. The methods were found to be reproducible from statistical data
generated.
High performanceliquid chromatograph (HPLC) was found to be
stability-indicating method for the quantitativ analysis of atorvastatin
calcium in precesne of its thermal , acid and photodecomposition
hydrolysis products .
The studies of photolysis and thermal degradation of atorvastatin calcium
in acid medium showed first order reaction kinetic and zero order reaction
kinetic in alkaline medium.
III
First derivate technique ID 236 was found to be suitable for estimation
of atorvastatin calcium in bulk and pharmaceutical dosage form. The
percentage recovery value 99.82% indicates the accuracy of the method
and absence of interference of the excipients present in the formulation.
The investigating of pharmaceutical excipients were found to
decrease the thermal stability of atorvastatin calcium with decreasing the
pH of excipients. The stability of atorvastatin calcium was in the following
order: Citric acid, magnesium stearate, microcrystalline cellulose, lactose,
tween 80, calcium carbonate, disodium phosphate and magnesium
hydroxide. Atorvastatin calcium was found to be more stable at
accelerating stability study for six months, but when exposed to direct
sunlight showed fast degradation in liquid state.
The methods were validated for the determination of losartan
potassium using the same column of determination atorvatatin and same
factorial design, the methods were satisfactory with correlation coefficient
in the range 6.4to 9.6μg/ml at wavelength 225 and 250nm respectively.
First derivative spectroscopy a signal at ID234 nm was found to be
adequate for quantification of losartan potassium.
Pharmaceutical excipients for losartan potassium formulation in
tablets were investigated as the function of pH of excipient; when the pH
deceased the degradation of losartan decreased also in the following order:
povidone K 30, magnesium stearate, microcrystalline cellulose, lactose,
maze starch and talc powder.
IV
Losartan potassium was found to be stable drug toward stress
testing, except when conducted at accelerating stability for six months it
showed significant degradation